Bayer Pharma, the global pharmaceutical division of Bayer based in Berlin, leads in pharmaceutical innovation with a strong focus on cancer treatment. Demonstrating leadership in advancing antibody-based immunotherapies, it recently partnered with Longwood Fund to support Pyxis Oncology. With a substantial public following, Bayer Pharma exemplifies commitment to pioneering healthcare solutions in oncology.

‌